XTRA:FYBBiotechs
Formycon (XTRA:FYB) Q3 Loss Highlights Ongoing Profitability Concerns Despite Bullish Growth Narratives
Formycon (XTRA:FYB) just posted its FY 2025 third quarter numbers, with revenue of €10.5 million and a net loss of €6.2 million, while basic EPS came in at a loss of €0.35. Over recent periods the business has seen quarterly revenue move between €4.5 million and €14.2 million, with EPS ranging from a loss of €1.53 to a gain of €3.84 on a trailing twelve month basis. This leaves investors weighing the current loss-making position against forecasts for strong earnings and revenue growth and...